Objective With 20 % of patients responding to their treatment and 10M dying every year, cancer is a recognised societal challenge. While data-driven approaches can double the clinical trials success rate, the pharma industry lacks tools to leverage the large amount of data generated in their drug discovery processes.We are developing mCUBE, an AI-powered platform that scales precision oncology for drug discovery and repurposing. Best-in-class and user-centric platform, mCUBE encapsulates a cancer-agnostic clinical data harmonisation module with an integrative approach to multi-omic data analysis. As our solution increases in value and allows us to move up the value chain, our initial SaaS business model will progressively switch to a drug discovery model. With mCUBE, we will identify and validate new drug candidates to license IP assets to pharma companies. By 2025, we expect to sign a deal of €25M with a biopharma partner. We will disrupt he oncology market for the benefits of cancer patients. Fields of science medical and health sciencesbasic medicinepharmacology and pharmacydrug discoverynatural sciencescomputer and information sciencesdata sciencesocial scienceseconomics and businessbusiness and managementbusiness modelsmedical and health sciencesclinical medicineoncology Keywords machine learning personalised medicine omic analysis drug discovery Programme(s) HORIZON.3.1 - The European Innovation Council (EIC) Main Programme HORIZON.3.1.2 - The Accelerator Topic(s) HORIZON-EIC-2021-ACCELERATOROPEN-01 - EIC Accelerator Open 2021 Call for proposal HORIZON-EIC-2021-ACCELERATOROPEN-01 See other projects for this call Funding Scheme HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended Finance Coordinator EPIGENE LABS SAS Net EU contribution € 2 495 788,75 Address 7 square gabriel faure 75017 Paris France See on map Region Ile-de-France Ile-de-France Paris Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 1 069 623,75
